FDA Panel Supports Down-Classification For ECMO Circuits
This article was originally published in The Gray Sheet
After much debate, FDA’s Circulatory System Devices panel formed a consensus in support of a class II, special controls designation for extracorporeal circuits for long-term pulmonary and cardiopulmonary support in adults.
You may also be interested in...
The Circulatory System Devices Panel supported class II, with special controls, reclassification proposals from FDA for extracorporeal membrane oxygenators; external cardiac compressors; and external pacemaker pulse generators and triple chamber pacing system analyzers. But the panel had some additional requests for further action by the agency.
ResMed plans to double or even triple production of intensive ventilators and sleep apnea machines this year amid rising demand by hospitals to use CPAP and BPAP machines to treat COVID-19 patients during the ventilator shortage.
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.